市场调查报告书

不孕治疗服务的全球市场

Fertility Services

出版商 Global Industry Analysts, Inc. 商品编码 957026
出版日期 内容资讯 英文 290 Pages
商品交期: 最快1-2个工作天内
价格
不孕治疗服务的全球市场 Fertility Services
出版日期: 2020年09月01日内容资讯: 英文 290 Pages
简介

全球不孕治疗服务的市场规模在2020年~2027年的期间中预计将以8%的年复合成长率增长,从2020年的227亿美元达到2027年390亿美元的规模。市场区隔之一的新鲜胚胎移植(非捐赠者)在分析期间结束前预测将以8.4%的年复合成长率增长,并达到218亿美元的规模。

本报告提供全球不孕治疗服务市场的相关调查,提供市场占有率,趋势和预测,成长要素,各地区的市场分析,竞争情形,主要企业的简介等资讯。

调查对象企业范例
  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

目录

I. 简介,调查手法 、 调查范围

II. 摘要整理

  • 市场概要
    • 竞争的市场占有率
    • 竞争的市场占有率方案
    • Covid-19影响与全球景气衰退
  • 主要企业
  • 趋势与成长要素
  • 全球市场预测

III. 市场分析

  • 各地区市场分析
  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他中东
  • 非洲

IV. 竞争

  • 企业简介:44公司
目录
Product Code: MCP11932

Global Fertility Services Market to Reach $39 Billion by 2027

Amid the COVID-19 crisis, the global market for Fertility Services estimated at US$22.7 Billion in the year 2020, is projected to reach a revised size of US$39 Billion by 2027, growing at a CAGR of 8% over the analysis period 2020-2027. Fresh Non-Donor, one of the segments analyzed in the report, is projected to record a 8.4% CAGR and reach US$21.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Frozen Non-Donor segment is readjusted to a revised 7.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.1 Billion, While China is Forecast to Grow at 12.2% CAGR

The Fertility Services market in the U.S. is estimated at US$6.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Egg and Embryo Banking Segment to Record 7.5% CAGR

In the global Egg and Embryo Banking segment, USA, Canada, Japan, China and Europe will drive the 6.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.4 Billion by the year 2027, while Latin America will expand at a 8.9% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 290-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Cryos International ApS
  • Eli Lilly and Company
  • EMD Serono, Inc.
  • Ferring Pharmaceuticals, Inc.
  • INVO Bioscience
  • Irvine Scientific
  • Ivftech Aps
  • Medical Electronic Systems, LLC.
  • Merck KGaA
  • Novartis AG
  • Pantec Biosolutions AG
  • Pfizer, Inc.
  • Sanofi SA
  • VIVUS, Inc.
  • Xytex Corporation

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Fertility Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 2: World Historic Review for Fertility Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 3: World 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 5: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 6: World 15-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 8: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 9: World 15-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Egg and Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 11: World Historic Review for Egg and Embryo Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 12: World 15-Year Perspective for Egg and Embryo Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 14: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 15: World 15-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 17: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 18: World 15-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 20: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 21: World 15-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 23: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 24: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 26: World Historic Review for Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 27: World 15-Year Perspective for Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 29: World Historic Review for Clinical Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 30: World 15-Year Perspective for Clinical Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Fertility Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 31: USA Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 32: USA Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 33: USA 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 35: USA Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 36: USA 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 38: Canada Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 39: Canada 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 41: Canada Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 42: Canada 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 43: Japan Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 44: Japan Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 45: Japan 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 46: Japan Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 47: Japan Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 48: Japan 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 49: China Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 50: China Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 51: China 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 52: China Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 53: China Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 54: China 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Fertility Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 55: Europe Current & Future Analysis for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 56: Europe Historic Review for Fertility Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 57: Europe 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 58: Europe Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 59: Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 60: Europe 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 61: Europe Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 62: Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 63: Europe 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 64: France Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 65: France Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 66: France 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 67: France Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 68: France Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 69: France 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 70: Germany Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 71: Germany Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 72: Germany 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 73: Germany Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 74: Germany Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 75: Germany 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 76: Italy Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 77: Italy Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 78: Italy 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 79: Italy Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 80: Italy Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 81: Italy 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 82: UK Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 83: UK Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 84: UK 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 85: UK Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 86: UK Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 87: UK 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 88: Spain Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 89: Spain Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 90: Spain 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 91: Spain Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 92: Spain Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 93: Spain 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 94: Russia Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 95: Russia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 96: Russia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 97: Russia Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 98: Russia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 99: Russia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 101: Rest of Europe Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 102: Rest of Europe 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 103: Rest of Europe Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 104: Rest of Europe Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 105: Rest of Europe 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 106: Asia-Pacific Current & Future Analysis for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 107: Asia-Pacific Historic Review for Fertility Services by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 108: Asia-Pacific 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 109: Asia-Pacific Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 110: Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 111: Asia-Pacific 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 112: Asia-Pacific Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 113: Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 114: Asia-Pacific 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 115: Australia Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 116: Australia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 117: Australia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 118: Australia Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 119: Australia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 120: Australia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 121: India Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 122: India Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 123: India 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 124: India Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 125: India Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 126: India 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 127: South Korea Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 128: South Korea Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 129: South Korea 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 130: South Korea Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 131: South Korea Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 132: South Korea 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 133: Rest of Asia-Pacific Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 134: Rest of Asia-Pacific Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 135: Rest of Asia-Pacific 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of Asia-Pacific Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 137: Rest of Asia-Pacific Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 138: Rest of Asia-Pacific 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 139: Latin America Current & Future Analysis for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 140: Latin America Historic Review for Fertility Services by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 141: Latin America 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 142: Latin America Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 143: Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 144: Latin America 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 145: Latin America Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 146: Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 147: Latin America 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 148: Argentina Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 149: Argentina Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 150: Argentina 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 151: Argentina Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 152: Argentina Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 153: Argentina 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 154: Brazil Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 155: Brazil Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 156: Brazil 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 157: Brazil Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 158: Brazil Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 159: Brazil 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 160: Mexico Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 161: Mexico Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 162: Mexico 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 163: Mexico Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 164: Mexico Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 165: Mexico 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 166: Rest of Latin America Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 167: Rest of Latin America Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 168: Rest of Latin America 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 169: Rest of Latin America Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 170: Rest of Latin America Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 171: Rest of Latin America 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 172: Middle East Current & Future Analysis for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through
    • TABLE 173: Middle East Historic Review for Fertility Services by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 174: Middle East 15-Year Perspective for Fertility Services by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 175: Middle East Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 176: Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 177: Middle East 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 178: Middle East Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 179: Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 180: Middle East 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 181: Iran Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 182: Iran Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 183: Iran 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 184: Iran Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 185: Iran Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 186: Iran 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 187: Israel Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 188: Israel Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 189: Israel 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 190: Israel Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 191: Israel Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 192: Israel 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 193: Saudi Arabia Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 194: Saudi Arabia Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 195: Saudi Arabia 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 196: Saudi Arabia Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 197: Saudi Arabia Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 198: Saudi Arabia 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 199: UAE Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 200: UAE Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 201: UAE 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 202: UAE Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 203: UAE Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 204: UAE 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 205: Rest of Middle East Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 206: Rest of Middle East Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 207: Rest of Middle East 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 208: Rest of Middle East Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 209: Rest of Middle East Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 210: Rest of Middle East 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 211: Africa Current & Future Analysis for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 212: Africa Historic Review for Fertility Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 213: Africa 15-Year Perspective for Fertility Services by Segment - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027
    • TABLE 214: Africa Current & Future Analysis for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through
    • TABLE 215: Africa Historic Review for Fertility Services by End-Use - Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through
    • TABLE 216: Africa 15-Year Perspective for Fertility Services by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 44